Physicians’ attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey
Objectives To investigate German physicians’ attitudes towards and experiences with voluntary disclosure of payments by pharmaceutical companies in a public database and their impact on future decisions for or against disclosure.Design A national cross-sectional survey conducted in 2018 among physic...
Saved in:
Main Authors: | Marlene Stoll, Lara Hubenschmid, Cora Koch, Klaus Lieb, Boris Egloff |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-06-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/6/e055963.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Voluntary Disclosures and their Drivers: A Study of MDA Reports in India
by: Himani Singla, et al.
Published: (2024-05-01) -
Effectiveness of the voluntary disclosure of corporate information and its commitment to climate change
by: F.G. Arredondo Trapero, et al.
Published: (2023-10-01) -
Contingency perspective: company characteristics, risk management voluntary disclosure, and company performance
by: Yuliusman Yuliusman, et al.
Published: (2023-09-01) -
INDEPENDENCE AND FINANCIAL EXPERTISE OF AUDIT COMMITTEE ON VOLUNTARY DISCLOSURE OF DEPOSIT MONEY BANKS IN NIGERIA
by: Saidu MUSA, et al.
Published: (2023-11-01) -
The Role of Firms’ Life Cycle Stages on Voluntary Disclosure and Cost of Equity Capital in Brazilian Public Companies
by: Paulo Victor Novaes, et al.
Published: (2020-01-01)